NCT01827631View on ClinicalTrials.gov

Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 27, 2013

Primary Completion Date

June 14, 2013

Study Completion Date

June 25, 2013

Conditions
Crohn's Disease
Interventions
DRUG

GSK1605786 capsule

Swedish Orange, size 0, hard gelatine capsules

Trial Locations (1)

200025

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01827631 - Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter